首页> 外文期刊>Journal of biomedical materials research, Part A >Chondrogenic differentiation of mesenchymal stem cells in a hydrogel system based on an enzymatically crosslinked tyramine derivative of hyaluronan
【24h】

Chondrogenic differentiation of mesenchymal stem cells in a hydrogel system based on an enzymatically crosslinked tyramine derivative of hyaluronan

机译:基于透明质酸的酶促交联酪胺衍生物的水凝胶系统中间充质干细胞的软弱化分化

获取原文
获取原文并翻译 | 示例
           

摘要

Hyaluronan-based tissue substitutes are promising materials in cartilage reconstruction surgery. Herein, the chondrogenesis of human mesenchymal stem cells (MSC) in a hydrogel based on a tyramine derivative of hyaluronan crosslinked by hydrogen peroxidase (HA-TA) was evaluated. Human MSC seeded in the scaffold were incubated in standard chondrogenic medium and medium enriched with bone morphogenetic protein-6 (BMP6). Cell viability, the gene expression of selected markers (collagen type II, aggrecan, SOX9, collagen type X, and osteopontin), and the histological characteristics were examined during three weeks of in vitro cultivation. The tissue reaction of both unseeded and MSC seeded HA-TA scaffolds were tested in vivo after subcutaneous application in rats for 12 weeks. The data showed that cells resisted the process of crosslinking and remained viable for the whole time while exhibiting changes in cell organization. Human MSC cultivated in HA-TA hydrogel expressed genes of both chondrogenic and osteogenic differentiation and the addition of BMP6 revealed a tendency to potentiate both processes. Histological analysis of HA-TA in vivo implants did not reveal a chronic inflammatory reaction. In both cases, in vivo HA-TA implants were continuously degraded and MSC-seeded hydrogels tended to form clusters similar to in vitro samples. In conclusion, MSC chondrogenic differentiation may proceed in a HA-TA scaffold that is biocompatible.
机译:基于透明质酸的组织替代品是软骨重建手术中有前途的材料。这里,基于透明化酶(HA-TA)交联的透明质酸酪氨硅衍生物的水凝胶中的人间充质干细胞(MSC)的细胞发生。在支架中播种的人体MSC在标准的软骨形成培养基中培养,富含骨形态发生蛋白-6(BMP6)。在体外培养的三周内检查了特定标记物(胶原II,II型,蛋白II,Exclecan,Sox9,胶原蛋白X和Osteopontin)的基因表达,以及组织学特征的基因表达。在大鼠的皮下施用后,在大鼠持续12周后,在体内进行无需和MSC种子HA-TA支架的组织反应。该数据显示,细胞抵抗交联的过程,并且整个时间仍然可行,同时表现出细胞组织的变化。在HA-TA水凝胶中培养的人体MSC表达了软骨内和骨质发生分化的基因,并且添加BMP6揭示了两种方法的趋势。体内植入物中HA-TA的组织学分析没有揭示慢性炎症反应。在这两种情况下,体内HA-TA植入物不断降解,并且MSC接种水凝胶倾向于形成与体外样品类似的簇。总之,MSC软弱化分化可以在生物相容性的HA-TA支架中进行。

著录项

  • 来源
  • 作者单位

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic Department of Physiology and;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic Medical Faculty in Hradec;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Contipro Biotech S.r.o. 401 561 02 Dolní Dobrou? Czech Republic;

    Institute of Biophysics Academy of Sciences of the Czech Republic Kralovopolska 135 612 65 Brno;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医用一般科学;
  • 关键词

    biocompatibility; chondrogenesis; hyaluronate; scaffold; tyramine;

    机译:生物相容性;软骨发生;透明质酸;脚手架;酪胺;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号